HSPA5 and central nervous system cancer: To further investigate induction of the RGD4C/AAVP‐Grp78 vector in human glioma by other anti‐cancer agents, known for their ability to cross the BBB, we treated human glioma cells with increasing concentrations of curcumin (0–40 μM).